India’s Caraco Pharma Wins U.S. Supreme Court To Market Generic
This article was originally published in PharmAsia News
Executive Summary
India’s Caraco Pharmaceuticals, the U.S. subsidiary of Sun Pharmaceutical Industries, won a unanimous U.S. Supreme Court verdict over Novo Nordisk.